GoodRx Holdings Inc. Class A (GDRX)
NASDAQ: GDRXTechnologyEDP ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
GDRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $996.14M
- P/E (TTM)
- 58.40
- Forward P/E
- 8.29
- EPS (TTM)
- $0.05
- Dividend yield
- None
- 52-week range
- 1.77 – 3.89
- Day range
- 2.91 – 3.09
- Volume / Avg
- 2.01M / 1.09M
- Beta
- —
- Shares outstanding
- 107.18M
- Next earnings
- Nov 24, 2026
52-week range
GDRX stock today
On Nov 20, GDRX ended the session at $2.92, shedding $0.10 (3.31%), versus the S&P 500's 3.70% decline. Shares are 24.9% below their 52-week high of $3.89, set on Aug 11, 2026 and 65.0% above the 52-week low of $1.77, in the middle of the past year's range. GDRX is up 7.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 7.7%.
At 58.4x trailing earnings, GoodRx trades above the peer-group median of 11.4x. Its forward P/E of 8.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Nov 24; analysts expect EPS of $0.04.
Summary generated from market data by MetaCap's automated system. Methodology
About GoodRx
Company profileGoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.
- Sector
- Technology
- Industry
- EDP Services
- CEO
- Ms. Wendy Barnes
- Headquarters
- Santa Monica, CA
- Employees
- 697
- IPO year
- 2020
- Website
- goodrx.com
Financial highlights
Full financialsIn fiscal 2025, GoodRx generated $796.9 million in revenue, up 0.6% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $30.4 million (+85.7% year over year), for a net margin of 3.8% versus a median of -3.4% in the prior 5 years. Gross margin was 92.8% (down from 93.9%) and operating margin 11.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $796.85M | $792.32M | $750.26M | $766.55M | $745.42M |
| Growth | +0.57% | +5.61% | -2.12% | +2.83% | +35.36% |
| Net income | $30.44M | $16.39M | $-8.87M | $-32.83M | $-25.25M |
| EPS (diluted) | $0.09 | $0.04 | $-0.02 | $-0.08 | $-0.06 |
Analyst forecast
ForecastConsensus (14 analysts)
hold
Avg. price target
$3.95+35.27%
- Strong buy 1
- Buy 3
- Hold 8
- Sell 0
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 24, 2026
- EPS estimate
- $0.04
- Last reported (Sep/2026)
- Nov 17, 2026
- EPS actual vs est.
- $0.04 vs $0.04
- Surprise
- 0.00%
GDRX news
All GDRX news- GoodRx becomes launch partner for Google Cloud’s Gemini for healthcareSeeking Alpha
- GoodRx stock rises on Google Cloud healthcare AI partnershipInvesting.com
- See if you qualify for the $32 million GoodRx data privacy settlement and learn how to protect your health informationCNBC
- Icon PLC (ICLR) Q3 Earnings and Revenues Beat EstimatesNasdaqICLR, GDRX
GoodRx peers
Technology sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WRDWeRide Inc. ADR | 2.99 | -8.58% | $981.93M | vs GDRX |
| INODInnodata Inc. | 28.12 | -8.91% | $966.84M | vs GDRX |
| UPWKUpwork Inc. | 8.55 | -2.40% | $1.08B | vs GDRX |
| PLTKPlaytika Holding Corp. | 2.31 | -7.97% | $883.98M | vs GDRX |
| OSPNOneSpan Inc. | 21.92 | -2.88% | $808.73M | vs GDRX |
| TASKTaskUs Inc. Class A | 8.72 | +0.17% | $799.90M | vs GDRX |
| DDIDoubleDown Interactive Co. Ltd. American Depository Shares | 15.31 | -0.26% | $758.66M | vs GDRX |
| LZLegalZoom.com Inc. | 4.47 | -1.97% | $738.26M | vs GDRX |
Indexes, lists and sector
Appears in lists
Largest Technology stocks
GoodRx stock FAQ
What is GoodRx's stock price today?
GDRX last traded at $2.92 as of Nov 20, 4:00 PM EST, down 3.31% on the day. Prices are delayed at least 15 minutes.
When is GoodRx's next earnings date?
GoodRx is expected to report earnings on Tuesday, November 24, 2026. Analysts expect EPS of $0.04.
What is GDRX's P/E ratio?
GDRX trades at a trailing P/E ratio of 58.40 and a forward P/E of 8.29, compared with a median of 11.4 for its closest peers.
Who is GoodRx's CEO?
Ms. Wendy Barnes is the chief executive officer of GoodRx Holdings Inc. Class A, which has about 697 employees.
What is the GDRX 52-week high?
The 52-week high for GDRX is $3.89 and the 52-week low is $1.77. The stock is currently 24.9% below its high.